Education
About Us
Working with TipRanks
Follow Us
Sotera Health (SHC)
NASDAQ:SHC
Earnings Data
Report Date
Aug 08, 2025Before Open (Confirmed)
Period Ending
2025 (Q2)Consensus EPS Forecast
0.17Last Year’s EPS
0.19Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Sotera Health demonstrated robust growth in revenues and EBITDA, notably in Nelson Labs and Nordion, and maintained a positive outlook for 2025. However, challenges such as the Cobalt-60 shipment timing, a GAAP net loss due to legal settlements, and revenue decline in Nelson Labs advisory services were noted. Despite these lowlights, the positive developments and reaffirmed growth outlook suggest a resilient performance.Company Guidance -
Q2 2025
Solid Start to 2025 with Revenue and EBITDA Growth
Sotera Health reported a 2.6% increase in total company revenues, or 4.4% on a constant currency basis, for Q1 2025 compared to Q1 2024. Adjusted EBITDA increased by 8.8%, or 11.2% on a constant currency basis.
Nelson Labs Margin Expansion
Nelson Labs achieved a 479 basis point margin expansion versus Q1 2024, marking the third consecutive quarter of year-over-year margin expansion.
Nordion's Strong Revenue Performance
Nordion's revenue increased by 36% to $33 million, or 40.6% on a constant currency basis, compared to Q1 2024. Segment income increased approximately 62%.
Reaffirmed 2025 Outlook
Sotera Health reaffirmed its 2025 outlook, expecting revenue growth in the range of 4% to 6% and adjusted EBITDA growth of 4.5% to 6.5% on a constant currency basis.
Successful Amendment to Revolving Credit Facility
The amendment added approximately $175 million in liquidity, extending maturity to April 2030.
FDA Clearance for Bionic Pancreas
Sotera Health played a critical role in securing FDA clearance for the first-ever bionic pancreas, showcasing the integrated expertise of Nelson Labs and Sterigenics.
SHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 01, 2025 | $11.50 | $12.10 | +5.22% |
Feb 27, 2025 | $13.64 | $12.28 | -9.97% |
Nov 05, 2024 | $15.80 | $15.42 | -2.41% |
Aug 05, 2024 | $13.22 | $14.22 | +7.56% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sotera Health (SHC) report earnings?
Sotera Health (SHC) is schdueled to report earning on Aug 08, 2025, Before Open (Confirmed).
What is Sotera Health (SHC) earnings time?
Sotera Health (SHC) earnings time is at Aug 08, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SHC EPS forecast?
SHC EPS forecast for the fiscal quarter 2025 (Q2) is 0.17.